While Congress and the Biden administration, as well as stakeholders across the prescription drug supply chain, examine policy options for addressing high drug prices, pharmacy benefit managers continue to create access to affordable medications for patients. But Medicare’s rebate rule is threatening to unwind PBMs’ ability to lower prescription drug costs. The time is now for Congress to repeal this costly rule.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.